p21(ras)-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms

Laura Kivinen, Erja Tiihonen, Tarja Haapajärvi, Marikki Laiho

Research output: Contribution to journalArticle

Abstract

Stable coexpression of the human retinoblastoma protein (pRB) cDNA and EJ c-Ha-ras oncogene in murine fibroblasts leads to loss of pRB expression with concomitant transformation of the cells (1). We show here that conditional expression of p21(ras) in mouse fibroblasts expressing human pRB leads to a rapid decrease of pRB expression at both protein and mRNA levels. The decrease of pRB mRNA is blocked by cycloheximide, suggesting the requirement of ongoing protein synthesis. p21(ras) expression leads also to decreases of c-myc and tissue metalloproteinase inhibitor-2 mRNAs, whereas cyclin-dependent kinase 4, cyclin D1, E2F-1, and ornithine decarboxylase are unaffected. The decrease in pRB is accompanied by progressive morphological transformation of the cells. The effect of p21(ras) on pRB expression was serum and growth factor dependent. A shift of the cells to low serum (0.2% FCS) abolished the effects of p21(ras) on pRB, but this effect was reconstituted by the addition of growth factors epidermal growth factor, fibroblast growth factor-2, transforming growth factor β1, and platelet- derived growth factor to the cells. The results suggest a complex interaction between p21(ras), pRB, and growth factors in the control of cell growth. p21(ras) appears to drive the cell cycle by deregulation of key cell cycle regulators, the functions of which in low serum become redundant or require the presence of growth factors positively driving the cell cycle.

Original languageEnglish (US)
Pages (from-to)1705-1712
Number of pages8
JournalCell Growth and Differentiation
Volume7
Issue number12
StatePublished - 1996
Externally publishedYes

Fingerprint

Proto-Oncogene Proteins p21(ras)
Retinoblastoma Protein
Intercellular Signaling Peptides and Proteins
Fibroblasts
Cell Cycle
Messenger RNA
Serum
Cyclin-Dependent Kinase 4
Tissue Inhibitor of Metalloproteinase-2
Ornithine Decarboxylase
ras Genes
Cyclin D1
Platelet-Derived Growth Factor
Transforming Growth Factors
Fibroblast Growth Factor 2
Cycloheximide
Epidermal Growth Factor
Proteins
Complementary DNA
Growth

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

p21(ras)-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms. / Kivinen, Laura; Tiihonen, Erja; Haapajärvi, Tarja; Laiho, Marikki.

In: Cell Growth and Differentiation, Vol. 7, No. 12, 1996, p. 1705-1712.

Research output: Contribution to journalArticle

@article{281dcb212ac642ff8e343396887476f7,
title = "p21(ras)-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms",
abstract = "Stable coexpression of the human retinoblastoma protein (pRB) cDNA and EJ c-Ha-ras oncogene in murine fibroblasts leads to loss of pRB expression with concomitant transformation of the cells (1). We show here that conditional expression of p21(ras) in mouse fibroblasts expressing human pRB leads to a rapid decrease of pRB expression at both protein and mRNA levels. The decrease of pRB mRNA is blocked by cycloheximide, suggesting the requirement of ongoing protein synthesis. p21(ras) expression leads also to decreases of c-myc and tissue metalloproteinase inhibitor-2 mRNAs, whereas cyclin-dependent kinase 4, cyclin D1, E2F-1, and ornithine decarboxylase are unaffected. The decrease in pRB is accompanied by progressive morphological transformation of the cells. The effect of p21(ras) on pRB expression was serum and growth factor dependent. A shift of the cells to low serum (0.2{\%} FCS) abolished the effects of p21(ras) on pRB, but this effect was reconstituted by the addition of growth factors epidermal growth factor, fibroblast growth factor-2, transforming growth factor β1, and platelet- derived growth factor to the cells. The results suggest a complex interaction between p21(ras), pRB, and growth factors in the control of cell growth. p21(ras) appears to drive the cell cycle by deregulation of key cell cycle regulators, the functions of which in low serum become redundant or require the presence of growth factors positively driving the cell cycle.",
author = "Laura Kivinen and Erja Tiihonen and Tarja Haapaj{\"a}rvi and Marikki Laiho",
year = "1996",
language = "English (US)",
volume = "7",
pages = "1705--1712",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - p21(ras)-mediated decrease of the retinoblastoma protein in fibroblasts occurs through growth factor-dependent mechanisms

AU - Kivinen, Laura

AU - Tiihonen, Erja

AU - Haapajärvi, Tarja

AU - Laiho, Marikki

PY - 1996

Y1 - 1996

N2 - Stable coexpression of the human retinoblastoma protein (pRB) cDNA and EJ c-Ha-ras oncogene in murine fibroblasts leads to loss of pRB expression with concomitant transformation of the cells (1). We show here that conditional expression of p21(ras) in mouse fibroblasts expressing human pRB leads to a rapid decrease of pRB expression at both protein and mRNA levels. The decrease of pRB mRNA is blocked by cycloheximide, suggesting the requirement of ongoing protein synthesis. p21(ras) expression leads also to decreases of c-myc and tissue metalloproteinase inhibitor-2 mRNAs, whereas cyclin-dependent kinase 4, cyclin D1, E2F-1, and ornithine decarboxylase are unaffected. The decrease in pRB is accompanied by progressive morphological transformation of the cells. The effect of p21(ras) on pRB expression was serum and growth factor dependent. A shift of the cells to low serum (0.2% FCS) abolished the effects of p21(ras) on pRB, but this effect was reconstituted by the addition of growth factors epidermal growth factor, fibroblast growth factor-2, transforming growth factor β1, and platelet- derived growth factor to the cells. The results suggest a complex interaction between p21(ras), pRB, and growth factors in the control of cell growth. p21(ras) appears to drive the cell cycle by deregulation of key cell cycle regulators, the functions of which in low serum become redundant or require the presence of growth factors positively driving the cell cycle.

AB - Stable coexpression of the human retinoblastoma protein (pRB) cDNA and EJ c-Ha-ras oncogene in murine fibroblasts leads to loss of pRB expression with concomitant transformation of the cells (1). We show here that conditional expression of p21(ras) in mouse fibroblasts expressing human pRB leads to a rapid decrease of pRB expression at both protein and mRNA levels. The decrease of pRB mRNA is blocked by cycloheximide, suggesting the requirement of ongoing protein synthesis. p21(ras) expression leads also to decreases of c-myc and tissue metalloproteinase inhibitor-2 mRNAs, whereas cyclin-dependent kinase 4, cyclin D1, E2F-1, and ornithine decarboxylase are unaffected. The decrease in pRB is accompanied by progressive morphological transformation of the cells. The effect of p21(ras) on pRB expression was serum and growth factor dependent. A shift of the cells to low serum (0.2% FCS) abolished the effects of p21(ras) on pRB, but this effect was reconstituted by the addition of growth factors epidermal growth factor, fibroblast growth factor-2, transforming growth factor β1, and platelet- derived growth factor to the cells. The results suggest a complex interaction between p21(ras), pRB, and growth factors in the control of cell growth. p21(ras) appears to drive the cell cycle by deregulation of key cell cycle regulators, the functions of which in low serum become redundant or require the presence of growth factors positively driving the cell cycle.

UR - http://www.scopus.com/inward/record.url?scp=0029658129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029658129&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 1705

EP - 1712

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 12

ER -